Summit Therapeutics Inc (SMMT) Price Prediction & ForecastSMMTSummit Therapeutics Inc

Alphio's SMMT stock price prediction model matches the current Summit Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.56 (+0.05%). The 1-week path is $15.74 (+1.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Summit Therapeutics Inc (SMMT) is currently priced at $14.63, which is significantly lower than the analyst price target of $43 from Citi, indicating potential upside. However, the RSI is at a low 25.011, suggesting the stock is oversold and may face further downward pressure in the short term. The company has experienced a 5-day change of -16.83% and a year-to-date change of -16.50%, indicating recent volatility and negative performance. The upcoming earnings report on October 19, 2026, could be a catalyst for movement, but the current financials show significant losses, with a projected EPS of -0.28. Given these factors, while there is potential for recovery, the risks associated with continued losses and market volatility suggest a hold position for now.

Summit Therapeutics Inc (SMMT) last closed at $15.55, losing -1.77%. These facts feed the 1-day and 1-week SMMT price prediction above.